NCT04657172 - Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

March 26, 2021

Study Completion Date

March 26, 2021

Conditions

Presbyopia

Interventions

DRUG

Pilocarpine Ophthalmic

Pilocarpine 1% or 2% ophthalmic solution administered with the Optejet microdose dispenser

DRUG

Placebo

Vehicle ophthalmic solution administered with the Optejet microdose dispenser

Trial Locations (9)

VISION-1 Study Site #50, New York

VISION-1 Study Site #51, Cranberry Township

VISION-1 Study Site #17, High Point

VISION-1 Study Site #22, Raleigh

VISION-1 Study Site #53, Orlando

VISION-1 Study Site #03, San Antonio

VISION-1 Study Site #54, Fort Collins

VISION-1 Study Site #21, Azusa

VISION-1 Study Site #52, Newport Beach